Dr Kumar Gubbala

Dr. Kumar Gubbala is a highly experienced Senior Consultant in Gynaecological Oncology at Apollo Proton Cancer Centre. He specialises in advanced open, laparoscopic, and robotic cancer surgeries for ovarian, cervical, uterine, and vulvar malignancies. His clinical focus includes HIPEC,cytoreductive surgery, and advanced treatments for recurrent gynaecological cancers.

Educational Qualification:

• MBBS from 2002
• MRCOG – Royal College of Obstetricians & Gynaecologists, London (2015)
• Postgraduate training in Obstetrics and Gynaecology from London and Oxford.

Professional Experience:

• 6–7 years of experience as a Gynaecological Oncologist at Apollo Proton Cancer Centre, Chennai.

Notable Achievements:

• AOI gold medal for the best Consultant paper
• TWJ Fellowship to visit the Causse Clinic, Beziers
• Silver medal for the best paper presentation at the Annual Conference
• Neuro-otological& Equilibriometric Society, New Delhi
• Travel grant, Section of Otology, Royal Society of Medicine
• Travelling Fellowship, Royal College of Physicians and
• Surgeons of Glasgow
• Scottish Otolaryngological Society prize for the best Registrar
• presentation at the annual S.O.S. meeting, Dumfries.
• Downs’ Temporal Bone Dissection Competition (1st Prize)
• (Royal National Throat, Nose and Ear Hospital , London ).
• Downs’ Temporal Bone Dissection Competition (2nd Prize)
• (Royal National Throat, Nose and Ear Hospital , London ).

Professional Memberships:

• Royal College of Obstetricians & Gynaecologists (MRCOG)
• British Gynaecological Cancer Society (BGCS)
• British Society for Colposcopy & Cervical Pathology (BSCCP)
• International Gynaecological Cancer Society (IGCS)‍

Fellowships:

• Fellowships in Gynaecological Oncology:The Royal Marsden Hospital, London. The Christies Cancer Hospital, Manchester, Oxford University Hospitals, Oxford.

Publications:

• Published over 25 articles in peer‑reviewed journals; contributed to books and chapters
• Involved in clinical trials and translational research with Cancer Research UK & University of Oxford